173 related articles for article (PubMed ID: 31317348)
1. Incidental breast carcinoma: incidence, management, and outcomes in 4804 bilateral reduction mammoplasties.
Tang R; Acevedo F; Lanahan C; Coopey SB; Yala A; Barzilay R; Li C; Colwell A; Guidi AJ; Cetrulo C; Garber J; Smith BL; Gadd MA; Specht MC; Hughes KS
Breast Cancer Res Treat; 2019 Oct; 177(3):741-748. PubMed ID: 31317348
[TBL] [Abstract][Full Text] [Related]
2. A Risk-Stratified Comparison of High-Risk Findings in Reduction Mammoplasty.
Dreifuss SE; Landfair AS; De La Cruz C
Ann Plast Surg; 2018 Jul; 81(1):36-38. PubMed ID: 29762441
[TBL] [Abstract][Full Text] [Related]
3. Occult disease in reduction mammoplasties and prophylactic mastectomies.
Nomikos A; Husain EA; Graham AD
Breast J; 2020 Apr; 26(4):691-696. PubMed ID: 31448509
[TBL] [Abstract][Full Text] [Related]
4. Incidental Findings in Reduction Mammoplasty Specimens in Patients with No Prior History of Breast Cancer. An Analysis of 783 Specimens.
Usón Junior PLS; Callegaro Filho D; Bugano DDG; Geyer FC; de Nigro Corpa MV; Gonçalves PDS; Simon SD; Kaliks RA
Pathol Oncol Res; 2018 Jan; 24(1):95-99. PubMed ID: 28391513
[TBL] [Abstract][Full Text] [Related]
5. Incidence of occult contralateral carcinomas of the breast following mastoplasty aimed at symmetrization.
Sorin T; Fyad JP; Pujo J; Colson T; Bordes V; Leroux A; Marchal F; Brix M; Simon E; Verhaeghe JL; Classe JM; Dolivet G
Ann Chir Plast Esthet; 2014 Apr; 59(2):e21-8. PubMed ID: 24530086
[TBL] [Abstract][Full Text] [Related]
6. A Look at the Other Side: High-Risk Lesions and Occult Contralateral Malignancy in Symmetry Procedures for Patients Undergoing Oncoplastic Breast-Conserving Surgery.
Jackson KM; Millen JC; Orozco JIJ; Stern SL; Fancher CE; Grumley JG
Ann Surg Oncol; 2023 Oct; 30(10):6159-6166. PubMed ID: 37535266
[TBL] [Abstract][Full Text] [Related]
7. Synchronous elective contralateral mastectomy and immediate bilateral breast reconstruction in women with early-stage breast cancer.
Gershenwald JE; Hunt KK; Kroll SS; Ross MI; Baldwin BJ; Feig BW; Ames FC; Schusterman MA; Singletary SE
Ann Surg Oncol; 1998 Sep; 5(6):529-38. PubMed ID: 9754762
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the feasibility of extended partial mastectomy and immediate reduction mammoplasty reconstruction as an alternative to mastectomy.
Chang EI; Peled AW; Foster RD; Lin C; Zeidler KR; Ewing CA; Alvarado M; Hwang ES; Esserman LJ
Ann Surg; 2012 Jun; 255(6):1151-7. PubMed ID: 22470069
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic mastectomy: pathologic findings in high-risk patients.
Khurana KK; Loosmann A; Numann PJ; Khan SA
Arch Pathol Lab Med; 2000 Mar; 124(3):378-81. PubMed ID: 10705389
[TBL] [Abstract][Full Text] [Related]
10. Bilateral reduction mammoplasty in combination with lumpectomy for treatment of breast cancer in patients with macromastia.
Chang E; Johnson N; Webber B; Booth J; Rahhal D; Gannett D; Johnson W; Franzini D; Zegzula H
Am J Surg; 2004 May; 187(5):647-50; discussion 650-1. PubMed ID: 15135684
[TBL] [Abstract][Full Text] [Related]
11. Experience with reduction mammaplasty combined with breast conservation therapy in the treatment of breast cancer.
Spear SL; Pelletiere CV; Wolfe AJ; Tsangaris TN; Pennanen MF
Plast Reconstr Surg; 2003 Mar; 111(3):1102-9. PubMed ID: 12621180
[TBL] [Abstract][Full Text] [Related]
12. Breast conservative surgery and local recurrence.
Rezai M; Kraemer S; Kimmig R; Kern P
Breast; 2015 Nov; 24 Suppl 2():S100-7. PubMed ID: 26432359
[TBL] [Abstract][Full Text] [Related]
13. Incidental breast carcinoma in reduction mammoplasty.
Huysmans M; Bronckaers M; Schillebeeckx C; Servaes D
Acta Chir Belg; 2017 Oct; 117(5):308-311. PubMed ID: 28610472
[TBL] [Abstract][Full Text] [Related]
14. The Management of Breast Cancer Detected by Reduction Mammaplasty.
Carlson GW
Clin Plast Surg; 2016 Apr; 43(2):341-7. PubMed ID: 27012792
[TBL] [Abstract][Full Text] [Related]
15. Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women's health centers.
Desouki MM; Li Z; Hameed O; Fadare O; Zhao C
Hum Pathol; 2013 Sep; 44(9):1877-81. PubMed ID: 23656973
[TBL] [Abstract][Full Text] [Related]
16. Skin-sparing mastectomy and immediate breast reconstruction: patient satisfaction and clinical outcome.
Salhab M; Al Sarakbi W; Joseph A; Sheards S; Travers J; Mokbel K
Int J Clin Oncol; 2006 Feb; 11(1):51-4. PubMed ID: 16508729
[TBL] [Abstract][Full Text] [Related]
17. Oncoplastic reduction mammoplasty for breast cancer in women with macromastia: Oncological long-term outcomes.
Emiroglu M; Salimoglu S; Karaali C; Sert I; Gungor O; Sert F; Aydın C
Asian J Surg; 2017 Jan; 40(1):41-47. PubMed ID: 26358362
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer after prophylactic mastectomy (bilateral or contralateral prophylactic mastectomy), a clinical entity: presentation, management, and outcomes.
Mutter RW; Frost MH; Hoskin TL; Johnson JL; Hartmann LC; Boughey JC
Breast Cancer Res Treat; 2015 Aug; 153(1):183-90. PubMed ID: 26210521
[TBL] [Abstract][Full Text] [Related]
19. Surgical and financial implications of genetic counseling and requests for concurrent prophylactic mastectomy.
Murphy RX; Adkinson JM; Namey T; Eid S; Bleznak A
Ann Plast Surg; 2010 May; 64(5):684-7. PubMed ID: 20395792
[TBL] [Abstract][Full Text] [Related]
20. Nipple-sparing mastectomy as treatment for patients with ductal carcinoma in situ: A 10-year follow-up study.
Lago V; Maisto V; Gimenez-Climent J; Vila J; Vazquez C; Estevan R
Breast J; 2018 May; 24(3):298-303. PubMed ID: 29139613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
